Premature Ventricular Complexes
10
3
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
10.0%
1 terminated out of 10 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Physical Impairments in Premature Ventricular Complex
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes
Sustained Auricular Nerve Stimulation for PVC Suppression
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy
Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias
Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy
WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Optimal EGM Configuration for Morphology Discrimination